Dr. Nikhil Khushalani, MD
Claim this profileMoffitt Cancer Center
Expert in Cancer
Studies Melanoma
19 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Melanoma
Stage IV
Stage III
BRAF positive
Affiliated Hospitals
Clinical Trials Nikhil Khushalani, MD is currently running
Darovasertib + Crizotinib
for Uveal Melanoma
This trial is testing a new drug combination (IDE196 and crizotinib) on patients with a specific type of eye cancer that has spread. The goal is to see if this combination can stop or slow down the cancer better than other treatments. Crizotinib has been used in treating various cancers with ALK gene rearrangements, showing high response rates.
Recruiting1 award Phase 2 & 38 criteria
Lenvatinib + Pembrolizumab
for Skin Cancer
This is a single arm trial of participants with Merkel cell carcinoma receiving a combination of lenvatinib plus pembrolizumab.
Recruiting1 award Phase 210 criteria
More about Nikhil Khushalani, MD
Clinical Trial Related1 year of experience running clinical trials · Led 19 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Nikhil Khushalani, MD has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- RP1
- Cemiplimab-Rwlc
- Relatlimab
Breakdown of trials Nikhil Khushalani, MD has run
Cancer
Melanoma
Squamous Cell Carcinoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nikhil Khushalani, MD specialize in?
Nikhil Khushalani, MD focuses on Cancer and Melanoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nikhil Khushalani, MD currently recruiting for clinical trials?
Yes, Nikhil Khushalani, MD is currently recruiting for 10 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Nikhil Khushalani, MD has studied deeply?
Yes, Nikhil Khushalani, MD has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Nikhil Khushalani, MD?
Apply for one of the trials that Nikhil Khushalani, MD is conducting.
What is the office address of Nikhil Khushalani, MD?
The office of Nikhil Khushalani, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.